Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Induction of Th2 responses reported for rhIL-4 in psoriatic patients

Dec. 10, 2002

Potential use of NO-releasing hydrogel dressing in wound healing

Dec. 10, 2002

Novel glucocorticoids in early development at GSK

Dec. 4, 2002

New data on a fixed combination of calcipotriol/betamethasone dipropionate in psoriasis

Dec. 2, 2002

T-cell depletion by alefacept reported effective in psoriatic lesions

Dec. 2, 2002

GAM product evaluated in phase I trial for diabetic foot ulcers

Nov. 29, 2002

PCL-016 enters phase IIa in acne

Nov. 28, 2002

SRP-299 enters phase II in childhood atopic dermatitis

Nov. 27, 2002

RegeneRx files IND for thymosin beta 4

Nov. 20, 2002

U. of British Columbia and ARC sign license agreement for novel antiinflammatories

Nov. 19, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...